Zobrazeno 1 - 9
of 9
pro vyhledávání: '"B. R. Vázquez Fuentes"'
Autor:
K. I. González Márquez, M. Eguia Bernal, Ernesto Torres-López, M. A. Garza Elizondo, Andres Mendiola-Jimenez, S. A. Loredo Alanis, D. D. Castañeda Martínez, M. M. Castañeda-Martínez, B. R. Vázquez Fuentes, P. Herrera-Sandate, G. E. Rodriguez-Sanchez, A. Cárdenas, Leendert A. Trouw, David Vega-Morales, D. Á. Galarza-Delgado, T. S. Gracia-Arechiga, Mario C. Salinas-Carmona, C. V. Solis
Publikováno v:
Annals of the Rheumatic Diseases. 80:1085-1086
Background:Clinically relevant anti-carbamylated (anti-CarP) antibodies are detected in up to 45% of rheumatoid arthritis (RA) patients and are associated with severe radiological progression, higher disease activity, and significantly more disabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a90b372a15adfdce541aa81f13b5104
https://doi.org/10.1136/annrheumdis-2021-eular.1289
https://doi.org/10.1136/annrheumdis-2021-eular.1289
Autor:
J. A. Esquivel Valerio, Y. G. Ordoñez Azuara, D. Á. Galarza-Delgado, R. F. Gutierrez-Herrera, G. Figueroa-Parra, M. A. Garza Elizondo, David Vega-Morales, B. R. Vázquez Fuentes, P. Herrera-Sandate
Publikováno v:
Annals of the Rheumatic Diseases. 80:445.1-445
Background:Clinically Suspect Arthralgia (CSA) was defined by European League Against Rheumatism to identify a combination of clinical features that best characterise patients with arthralgia who are at risk of progression to rheumatoid arthritis (RA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4330d1cb6c9598bd04b8ccd0d9da0196
https://doi.org/10.1136/annrheumdis-2021-eular.3754
https://doi.org/10.1136/annrheumdis-2021-eular.3754
Autor:
M. A. Garza Elizondo, Y. G. Ordoñez Azuara, D. Á. Galarza-Delgado, R. F. Gutierrez-Herrera, G. Figueroa-Parra, P. Herrera-Sandate, B. R. Vázquez Fuentes, J. A. Esquivel Valerio, David Vega-Morales
Publikováno v:
Annals of the Rheumatic Diseases. 80:1425.1-1425
Background:Early referral of patients with suspicion of progression to rheumatoid arthritis (RA) is of paramount importance in disease prognosis. We had previously described a time delay of 28 months between symptom onset and evaluation by a rheumato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1ff0618d97311839f9e5ad89703c158
https://doi.org/10.1136/annrheumdis-2021-eular.4095
https://doi.org/10.1136/annrheumdis-2021-eular.4095
Autor:
G. Figueroa-Parra, D. Á. Galarza-Delgado, B. R. Vázquez Fuentes, Janett Riega-Torres, David Vega-Morales, L. Á. Ceseñas-Falcón, C. M. Gamboa-Alonso
Publikováno v:
Annals of the Rheumatic Diseases. 80:1177.3-1177
Background:Primary SjÖgren´s Syndrome (PSS) is an autoimmune disease characterized by sicca symptoms, autoantibodies and lymphocytic infiltrate in exocrine glands.Classification and diagnosis of PSS is performed by applying 2002 AECG, 2012 ACR or 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b97f8d2e0dfab286f509ba3e225ad6b1
https://doi.org/10.1136/annrheumdis-2021-eular.922
https://doi.org/10.1136/annrheumdis-2021-eular.922
Autor:
G. Figueroa-Parra, C. M. Gamboa-Alonso, B. R. Vázquez Fuentes, J. D. Ángulo, David Vega-Morales, M. J. Garza Martínez, Janett Riega-Torres, D. Á. Galarza-Delgado
Publikováno v:
Annals of the Rheumatic Diseases. 79:1046.2-1046
Background:Minor salivary gland biopsy (MSGB) portrays an important role as part of the diagnostic criteria of primary Sjögren’s syndrome (pSS) in the ACR/EULAR 2016 classification. Autoantibodies anti-Ro/SSA and anti-La/SSB embody part of these c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b80f559374876ace6b018977fcdd64d5
https://doi.org/10.1136/annrheumdis-2020-eular.6278
https://doi.org/10.1136/annrheumdis-2020-eular.6278
Autor:
Y. G. Ordoñez Azuara, David Vega-Morales, M. M. Castañeda-Martínez, G. Figueroa-Parra, J. M. Calderón Espinosa, B. R. Vázquez Fuentes, J. A. Esquivel Valerio, D. Á. Galarza-Delgado
Publikováno v:
Annals of the Rheumatic Diseases. 79:1967.1-1968
Background:Primary care physicians (PCP) are the first point of contact for patients with a new-onset inflammatory rheumatic disease, like rheumatoid arthritis (RA). Consequently, primary care is crucial to the early diagnosis and prompt treatment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb7dab774f1482da91eca95a5a80efa6
https://doi.org/10.1136/annrheumdis-2020-eular.4728
https://doi.org/10.1136/annrheumdis-2020-eular.4728
Autor:
I. D. J. Hernandez-Galarza, D. Á. Galarza-Delgado, L. Santoyo-Fexas, C. M. Skinner Taylor, C. V. Solis, B. R. Vázquez Fuentes, R. A. Uriarte Botello, M. Eguia Bernal
Publikováno v:
Annals of the Rheumatic Diseases. 79:1935.1-1936
Background:Pharmacovigilance is the science and activities related to detection, evaluation, understanding and prevention of adverse effects of medications or any other health problem related to them. (1)Within the scope of the pharmacovigilance stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57dcd10686b1a7b5f6286225d816abea
https://doi.org/10.1136/annrheumdis-2020-eular.2218
https://doi.org/10.1136/annrheumdis-2020-eular.2218
Autor:
M. Eguia Bernal, R. A. Uriarte Botello, D. Á. Galarza-Delgado, B. R. Vázquez Fuentes, L. Santoyo-Fexas, C. M. Skinner Taylor, I. D. J. Hernandez-Galarza, C. V. Solis
Publikováno v:
Annals of the Rheumatic Diseases. 79:1936-1936
Background:Medication error can be defined as a failure in the treatment process that leads to or has the potential to lead to harm to the patient, this fault can happen in two different phases: prescribing and prescription.Prescribing is the process
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b81a515c57517160aeb0b6a10b1d3fd1
https://doi.org/10.1136/annrheumdis-2020-eular.2940
https://doi.org/10.1136/annrheumdis-2020-eular.2940
Autor:
David Vega-Morales, G. Figueroa-Parra, B. R. Vázquez Fuentes, J. A. Esquivel Valerio, D. Á. Galarza-Delgado, Y. G. Ordoñez Azuara, M. M. Castañeda-Martínez
Publikováno v:
Annals of the Rheumatic Diseases. 79:1931.3-1931
Background:Primary care physicians (PCP) are usually the first contact of people with inflammatory rheumatic diseases, and find the early symptoms of Rheumatoid Arthritis (RA) difficult to distinguish from those of other rheumatic diseases. A time-de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e18c6b135868a89f2cdf92a6e82fbae
https://doi.org/10.1136/annrheumdis-2020-eular.4515
https://doi.org/10.1136/annrheumdis-2020-eular.4515